About Von Willebrand Disease — What is VWD
The Humate-P® Difference: High Quality & Quantity
Home Infusion Video
Mix2Vial™ Needle-Free transfer Device
The CSL Behring Commitment
Resources and Tools

Request More Information
Patient Education Materials
AllAboutBleeding.com
Glossary of Terms
News & Events
Important Safety Information
Prescribing Information
Request More Information
For Healthcare Professionals
      

Request More Information

If your question is about a medical condition, then you should consult with a healthcare professional or, in the case of an emergency, call 911 immediately.
Please Contact Us for additional information.
 
Yes, I would like to receive relevant information about Humate-P®, von Willebrand disease, and CSL Behring products, programs, and services.
 
All fields marked with an asterisk (*) are required.
 
*Salutation:
*First Name:
*Last Name:
*I am a:
This is my: Home Address
Work Address
*Address 1:
Address 2:
*City:
*State:
*ZIP Code:
Telephone Number:
*E-mail Address:
*Confirm E-mail Address:
 
*My key area of interest is (check all that apply):
 Hemophilia A
 Hemophilia B
 von Willebrand disease
 
 
I would like to receive a reusable infusion mat to use when mixing Humate-P®. Please note: This offer is limited to one infusion mat per request on Web site.
 
Educational Materials
 
I would like the following educational materials sent to me. (If you would like to request additional quantities, please contact Consumer Affairs at 1-888-508-6978.)
 
Introducing You to VWD and Humate-P®—This brochure offers newly diagnosed patients help in managing their condition while providing important information about Humate-P® as a treatment option.
 
Humate-P® Consumer Brochure—For patients who want a more in-depth look at Humate-P®, this brochure discusses high molecular weight multimers, the viral safety of Humate-P®, and the clot formation process.
 
Patient's Guide to Understanding VWD—This booklet talks about the disorder, symptoms, and diagnosis, and provides general information on treatment options.
 
VWD, Menstruation, and Your Daughter—Women with VWD may experience menorrhagia during menstruation, and this booklet helps parents explain to their pre-teen daughters how VWD may affect them.
 
Diane Dino's Dilemma—This beautifully illustrated children's book tells the encouraging story of how a young dinosaur (Diane Dino) finds out she has VWD.
 
 

*Type in the verification word in the box below and hit "Submit":



  


Prior to submitting your information, please review our Privacy Policy.
 
I would like to unsubscribe from this e-mail program.


Important Safety Information

Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized, Humate-P® is indicated in adult patients for treatment and prevention of bleeding in hemophilia A (classical hemophilia). Humate-P® is also indicated in adult and pediatric patients with von Willebrand disease (VWD) for (1) treatment of spontaneous and trauma-induced bleeding episodes, and (2) prevention of excessive bleeding during and after surgery. This applies to patients with severe VWD, and patients with mild and moderate VWD for whom use of desmopressin is known or suspected to be inadequate.

Humate-P® is contraindicated in individuals with a history of anaphylactic or severe systemic response to antihemophilic factor or von Willebrand factor preparations or to any of its components.

Thromboembolic events have been reported in VWD patients receiving coagulation factor replacement, especially in the setting of known risk factors for thrombosis. Caution should be exercised and antithrombotic measures considered.

Humate-P® is derived from human plasma. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob disease (CJD) agent, cannot be completely eliminated.

Although few adverse reactions have been reported the most common are allergic-anaphylactic reactions, including urticaria, chest tightness, rash, pruritus, edema, shock, chills and fever, and hypervolemia. For patients undergoing surgery, the most common adverse reactions are postoperative wound or injection-site bleeding.

Please see accompanying full prescribing information for Humate-P®.